Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
48.64
-1.01 (-2.03%)
At close: Mar 20, 2026

SHA:688192 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-845.96-1,108-736-669.88
Depreciation & Amortization
64.2165.5858.4353.72
Other Amortization
12.817.14.641.86
Loss (Gain) From Sale of Assets
-0.01-0.02-
Loss (Gain) From Sale of Investments
-14.45-22.52-42.16-2.37
Stock-Based Compensation
--27.8961.97
Provision & Write-off of Bad Debts
-0.120.4-0.020
Other Operating Activities
-68.496.6-5.179.4
Change in Accounts Receivable
23.7-57.22-0.72-17.93
Change in Inventory
-20.64-18.4-5.07-
Change in Accounts Payable
65.6-38.3394.8370.93
Change in Other Net Operating Assets
132.82196.61--
Operating Cash Flow
-650.53-967.88-603.37-492.28
Capital Expenditures
-137.58-32.13-73.78-8.98
Sale of Property, Plant & Equipment
-00-
Investment in Securities
99.5643.32458.34-1,620
Other Investing Activities
---1.68
Investing Cash Flow
-38.07611.19384.56-1,627
Short-Term Debt Issued
---19.54
Long-Term Debt Issued
963.36338.23--
Total Debt Issued
963.36338.23-19.54
Short-Term Debt Repaid
----19.54
Long-Term Debt Repaid
-233.51-26.32-22.14-18.01
Total Debt Repaid
-233.51-26.32-22.14-37.55
Net Debt Issued (Repaid)
729.85311.91-22.14-18.01
Issuance of Common Stock
158.271.253.752,022
Common Dividends Paid
-20.55-3.38--
Other Financing Activities
-0.55-1.53-14.88-22.45
Financing Cash Flow
867.01308.25-33.261,981
Foreign Exchange Rate Adjustments
-2.450.979.52-6.33
Net Cash Flow
175.96-47.47-242.56-144.78
Free Cash Flow
-788.1-1,000-677.15-501.26
Free Cash Flow Margin
-218.98%-1095.44%--4873.51%
Free Cash Flow Per Share
-1.90-2.46-1.67-1.39
Cash Interest Paid
---0.05
Cash Income Tax Paid
20.7-5.18-68.69-25.17
Levered Free Cash Flow
-423.64-596.9-468.46-234.15
Unlevered Free Cash Flow
-409.42-592.17-465.75-232.23
Change in Working Capital
201.4782.6689.0553.01
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.